The toxicity and antiviral activity of extracts obtained by the methods of aqueous and ethanol extraction of bioactive substances from Cetraria islandica lichen as a raw material were studied. Aqueous and ethanol extracts of lichen were characterized by low toxicity with respect to the passaged MDCK cell culture and exhibited antiviral activity. The ethanol extract showed more potent in vitro antiviral activity against human A/H3N2 and avian A/H5N1 influenza viruses: in a concentration of 50 μg/ml, it suppressed replication of these viruses by 3.5 and 4 log10, respectively, while the aqueous extract inhibited replication of viruses by 2 and 6 log10, respectively, when taken in a concentration of 500 μg/ml that was 10-fold higher than the concentration of the ethanol extract.
Similar content being viewed by others
References
Ershov FI, Romantsev MG. Medicines Used for Viral Diseases. Moscow, 2007. Russian.
Skvortsov VV, Tumarenko AV, Skvortsova EM. Topical issues of diagnosis and treatment of influenza. Poliklinika. 2012;(2-1):104-107. Russian.
Watts J. Asian nations step up action to curb spread of avian influenza. Outbreak is spreading at an unprecedented speed, WHO says, and nowhere can be considered safe. Lancet. 2004;363:373. https://doi.org/10.1016/s0140-6736(04)15475-5
Kirilyuk A, Petrishche T. Antiviral medicines as a major aspect of pharmaceutical care for diseases caused by acute respiratory viral infections and influenza virus. Retsept. 2019;22(5):727-743. Russian.
World Health Organization. WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus. World Health Organization, 2006. URL: https://apps.who.int/iris/handle/10665/69373
Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res. 2008;78(1):91-102. https://doi.org/10.1016/j.antiviral.2008.01.003
Sokolov DN, Luzina OA, Polovinka MP, Salakhutdinov NF, Kiselev OI, Zarubaev VV, Shtro AA. Patent RU No. 2464033. Usnic acid and its oxidated derivative as influenza virus reproduction inhibitors. Bull. No. 29. Published October 20, 2012.
Mazurkova NA, Sedelnikova NV, Filippova EI, Makarevich EV, Kostina NE, Kukushkina TA. Patent RU No. 2580305. Antiviral agent based on dry extract of lichen Cetraria islandica. Bull. No. 10. Published April 10, 2016.
Rebrova OYu. Statistical Analysis of Medical Data: Application of the STATISTICA Software Package. Moscow, 2006. Russian.
Makarevich EV, Ibragimova ZhB, Mazurkov OYu, Filippova EI, Gorbunova IA, Mazurkova NA. Chemical composition and antiviral properties of fruit body extracts from gasteromycetes of Western Siberia. Eksper. Klin. Farmakol. 2017;80(5):33-37. Russian. https://doi.org/10.30906/0869-2092-2017-80-5-33-37
Manual on Experimental (Preclinical) Study of New Pharmacological Substances. Khabriev RU, ed. Moscow, 2005. Russian.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 175, No. 2, pp. 177-181, February, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Makarevich, E.V., Filippova, E.I., Sedel’nikova, N.V. et al. Anti-Influenza Activity of Cetraria islandica Lichen Extracts in In Vitro Experiments. Bull Exp Biol Med 175, 215–218 (2023). https://doi.org/10.1007/s10517-023-05837-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-023-05837-8